Samba-AC: A Randomized, Open-Label, Cross-Over Study to Investigate the PK and PD Profiles of Dance 501 (Human Insulin Inhalation Solution and Inhaler) in Healthy Subjects and Non-Diabetic Subjects With Mild to Moderate Asthma or COPD
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2019
Price : $35 *
At a glance
- Drugs Insulin (Primary) ; Insulin lispro
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Acronyms Samba-AC
- Sponsors Dance Biopharm
- 11 Sep 2019 Status changed from recruiting to discontinued.
- 23 Feb 2019 Planned End Date changed from 30 Aug 2018 to 30 Aug 2019.
- 23 Feb 2019 Planned primary completion date changed from 30 Jul 2018 to 30 Jul 2019.